1. Home
  2. KRYS vs RNST Comparison

KRYS vs RNST Comparison

Compare KRYS & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • RNST
  • Stock Information
  • Founded
  • KRYS 2015
  • RNST 1904
  • Country
  • KRYS United States
  • RNST United States
  • Employees
  • KRYS N/A
  • RNST N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • RNST Major Banks
  • Sector
  • KRYS Health Care
  • RNST Finance
  • Exchange
  • KRYS Nasdaq
  • RNST Nasdaq
  • Market Cap
  • KRYS 4.3B
  • RNST 3.3B
  • IPO Year
  • KRYS 2017
  • RNST N/A
  • Fundamental
  • Price
  • KRYS $152.08
  • RNST $37.24
  • Analyst Decision
  • KRYS Strong Buy
  • RNST Buy
  • Analyst Count
  • KRYS 11
  • RNST 6
  • Target Price
  • KRYS $204.27
  • RNST $42.20
  • AVG Volume (30 Days)
  • KRYS 273.6K
  • RNST 559.6K
  • Earning Date
  • KRYS 08-04-2025
  • RNST 07-22-2025
  • Dividend Yield
  • KRYS N/A
  • RNST 2.37%
  • EPS Growth
  • KRYS 109.01
  • RNST N/A
  • EPS
  • KRYS 4.16
  • RNST 2.24
  • Revenue
  • KRYS $333,448,000.00
  • RNST $735,631,000.00
  • Revenue This Year
  • KRYS $40.10
  • RNST $40.84
  • Revenue Next Year
  • KRYS $49.73
  • RNST $13.45
  • P/E Ratio
  • KRYS $36.60
  • RNST $16.60
  • Revenue Growth
  • KRYS 247.53
  • RNST 17.24
  • 52 Week Low
  • KRYS $122.80
  • RNST $26.97
  • 52 Week High
  • KRYS $213.52
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 58.86
  • RNST 50.27
  • Support Level
  • KRYS $147.35
  • RNST $35.79
  • Resistance Level
  • KRYS $154.99
  • RNST $39.41
  • Average True Range (ATR)
  • KRYS 4.29
  • RNST 0.88
  • MACD
  • KRYS 0.08
  • RNST -0.26
  • Stochastic Oscillator
  • KRYS 66.32
  • RNST 40.06

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: